- Product description
- Mercaptopurine Tablets, USP, 50 mg, packaged in a) 60-count tablets per bottle (NDC 49884-922-02) and b) 250-count tablets per bottle (NDC 49884-922-04), Rx only, Distributed by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977.
- Product quantity
- a) 25,516 bottles; b) 2,569 bottles
- Reason for recall
- Failed USP Dissolution Test Requirements: The recalled lots do not meet the specification for dissolution.
- Recall initiation reason
- —
- Initial firm notification
- Letter
- Distribution pattern
- Nationwide and Puerto Rico.